Fulgent Genetics, Inc.
US ˙ NasdaqGM ˙ US3596641098

SecurityFLGT / Fulgent Genetics, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership74,552 shares
Latest Disclosed Value $ 1,958,483
Sei Investments Co reports 0.20% increase in ownership of FLGT / Fulgent Genetics, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 74,552 shares of Fulgent Genetics, Inc. (US:FLGT) valued at $1,958,481 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 74,403 shares of Fulgent Genetics, Inc.. This represents a change in shares of 0.20% during the quarter. The current value of the position is $1,352,373 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F FULGENT GENETICS COM 359664109 74,552 149 0.20 1,958 16.48 0.0019
2025-11-13 2025-09-30 13F FULGENT GENETICS COM 359664109 74,403 -15 -0.02 1,682 13.66 0.0018
2025-08-14 2025-06-30 13F FULGENT GENETICS COM 359664109 74,418 958 1.30 1,479 19.18 0.0017
2025-05-14 2025-03-31 13F/A-1 FULGENT GENETICS COM 359664109 73,460 -5,998 -7.55 1,241 -15.41 0.0016
2025-05-13 2025-03-31 13F FULGENT GENETICS COM 359664109 79,458 0 1,468 0.0016
2025-02-11 2024-12-31 13F FULGENT GENETICS COM 359664109 79,458 -14,747 -15.65 1,468 -28.33 0.0019
2024-11-12 2024-09-30 13F FULGENT GENETICS COM 359664109 94,205 94,205 2,047 0.0027
2023-02-10 2022-12-31 13F FULGENT GENETICS COM 359664109 0 -19,170 -100.00 0 -100.00
2022-11-14 2022-09-30 13F FULGENT GENETICS COM 359664109 19,170 -638 -3.22 731 -32.31 0.0016
2022-08-15 2022-06-30 13F FULGENT GENETICS COM 359664109 19,808 -115 -0.58 1,080 -13.11 0.0023
2022-05-13 2022-03-31 13F FULGENT GENETICS COM 359664109 19,923 19,923 1,243 0.0025
2020-12-04 2020-09-30 13F/A-1 FULGENT GENETICS COM 359664109 0 -16,525 -100.00 0 -100.00
2020-08-11 2020-06-30 13F FULGENT GENETICS COM 359664109 16,525 0 0.00 213 19.66 0.0007
2020-05-14 2020-03-31 13F FULGENT GENETICS COM 359664109 16,525 0 0.00 178 -16.43 0.0007
2020-02-06 2019-12-31 13F FULGENT GENETICS COM 359664109 16,525 16,525 213 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.